BLTE Competitors & Alternatives
Compare Belite Bio Inc ADR with similar stocks in the same industry
Biotechnology
BLTE
Main Stock$169.96
Tradestie Score
45
Market Cap
$2.41B
Analyst Upside
+33.8%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$56.16
|
$6.68B | - | 65 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$109.86
|
$6.64B | - | 31 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$90.20
|
$6.38B | - | 64 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$18.54
|
$6.03B | - | 42 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$42.62
|
$6.02B | - | 49 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$144.37
|
$5.92B | - | 55 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$64.56
|
$5.80B | 98.1 | 30 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$305.68
|
$5.20B | 42.0 | 50 | Compare |
More BLTE Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry